Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.
This bill adds xylazine to New Jersey's Schedule III controlled substances list, meaning it is now classified as a controlled drug with specific legal restrictions. The exception explicitly allows veterinarians to prescribe, administer, or dispense xylazine for animal care without violating the law. Illegally possessing, distributing, or using xylazine would become a third-degree crime, punishable by up to five years in prison and fines up to $35,000. This change directly affects people who misuse xylazine outside of veterinary contexts, while leaving veterinary practice unaffected.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 13, 2026
Last action Jan 13, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
Jan 13, 2026
Introduced
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
upper
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about S 2036
Scope: NJ
Hi! I can help you understand S 2036. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline